Kingstone Companies (KINS): the turnaround Wall Street hasn't re-rated

Kingstone lost money every year from 2021 through 2023 — the kind of record that gets a small NASDAQ Capital Market insurer filtered out by any screen that looks at trailing profitability before it looks at anything else. By the time the turnaround actually showed up in the numbers, the stock had already been categorized as a name not worth revisiting.

Coverage Gap

Kingstone [FMP] market cap $293M writes property and casualty insurance almost entirely in one state: for both 2025 and 2024, 98.0% and 96.0% of its subsidiary Kingstone Insurance Company's direct written premium came from New York policies

It was the 12th largest homeowners writer in the state in 2024. A single-state, catastrophe-exposed personal-lines book is exactly the kind of business that produces the multi-year loss stretch this company just had — 2021 through 2023 were all net losses — and exactly the kind of business a quant screen or a generalist analyst has no reason to look at twice once that happens. The coverage gap here isn't a misunderstood business model; it's a real distressed period that already ended in the filed numbers, before the market finished pricing it as over.

Business

Kingstone Insurance Company underwrites personal lines — homeowners, dwelling fire, co-op/condo, renters, and personal umbrella — plus commercial auto physical-damage policies for livery and taxi fleets, distributed through retail and wholesale agents and brokers

Revenue (net premiums earned plus investment and other income) grew from $155.1M in FY2024 to $214.9M in FY2025, a 38.5% increase. Part of that growth is not organic: on April 14, 2025, Kingstone entered a New York Department of Financial Services-approved renewal-rights agreement to offer replacement policies to homeowners customers of a competitor — widely identified in company disclosures by the "AmGuard" name — that was withdrawing roughly $70M of written premium from the admitted personal-lines market in the state

Separately, the company's own Q1 2026 filing reports direct written premiums up 19.6% year-over-year and personal-lines premium up 21.4%, attributed primarily to "organic growth from the Change in Market Dynamics in the New York market" and secondarily to rate increases tied to replacement costs

The filings don't isolate exactly how much of FY2025's growth came from the AmGuard book versus organic renewal-rate and market-share gains, so the two should be read as overlapping tailwinds, not cleanly separated ones.

Moat / Mispricing

The plausible edge is underwriting specialization in catastrophe-exposed New York risk that larger, more diversified national carriers are actively exiting — the AmGuard withdrawal is a direct example of a competitor pulling back from exactly the market Kingstone specializes in. That's a real mechanism (regulatory approval, an established distribution network, and underwriting expertise built specifically around this book are not trivial to replicate), but it's also concentration risk wearing a moat's clothing: the same New York-only book that lets Kingstone pick up an exiting competitor's policies is the book that produced three straight loss years when catastrophe experience ran hot.

The more interesting mispricing candidate is the expense-ratio trend. The net underwriting expense ratio improved from 31.3% in FY2024 to 30.0% in FY2025, and continued improving into Q1 2026 (30.4% versus 31.3% in Q1 2025), with the filing attributing part of the gain to economies of scale as net premiums earned grew faster than employment costs

An improving expense ratio alongside premium growth is the signature of operating leverage, not a one-time item — but the filings don't disclose how much of FY2025's net income also depended on a benign catastrophe year rather than the expense-ratio trend alone, and 2021-2023 already showed how fast that can reverse.

Capital Allocation

Kingstone spent 2025 cleaning up its balance sheet rather than just growing it. It fully prepaid its 13.75% senior notes due 2026 in two installments ($3.5M in January, $2.45M in February, plus accrued interest), retiring expensive fixed-rate debt

It sold its Kingston, New York headquarters building to Ulster County for $3.6M, closing in March 2025

And effective July 1, 2025 it raised the top limit of its catastrophe reinsurance program from $280M to $440M, which the company describes as calibrated to a 1-in-100-year storm event under its primary catastrophe model — a materially larger cushion than it carried during the 2021-2023 loss years

Stockholders' equity reflects the turnaround directly: $34.5M at the end of FY2023 versus $122.7M at the end of FY2025, a 3.6x increase — but retained earnings alone (FY2024 plus FY2025 net income, about $59.1M combined) only explains roughly two-thirds of that $88.2M rise. The rest is not a mystery so much as a mix this desk can name but not fully size from the cache: 2025 comprehensive income ($46.9M)

ran ahead of net income ($40.8M), consistent with unrealized gains on the investment portfolio; and the company's 10-K separately discloses that warrants tied to its 2022/2024 debt-exchange agreements (a tranche covering 969,225 shares) were exercised in December 2025

and weighted-average diluted shares outstanding rose 13.8% in FY2025 alone (12.42M to 14.14M) — real dilution, not the earnings-only story a first read of the equity line suggests. The company also initiated a $0.05-per-share quarterly dividend in mid-2025

and announced a 5-Year Growth Plan targeting $500M in direct written premium by 2029 — roughly double its current scale — through a mix of organic growth and geographic expansion, starting with a planned entry into California's excess and surplus lines market in Q2 2026

Paying down debt, raising the reinsurance cushion, initiating a dividend, and funding geographic expansion simultaneously is a very different capital position than the company had during the loss years — but the share count is growing alongside the earnings, which dilutes some of the per-share benefit of the turnaround.

Risks

Self-checking the desk's usual blind spots against this specific name:

• Technology-speed risk: catastrophe modeling and climate-risk repricing are moving targets for any concentrated-geography insurer; a faster-than- expected shift in reinsurance market pricing or in how regulators let Kingstone reprice risk in New York could compress margins faster than the 5-Year Growth Plan assumes.
• Key-person / governance risk: Gregory Fortunoff held a negotiated Board observer seat from March 2023 until December 2024, when he and Scott Fortunoff voluntarily gave it up, stating in the company's own disclosure that "based upon the recent performance of the Company," they believed "there is no need for the continuation" of that oversight role [SEC] 8-K, Fortunoff Agreement Amendment The Fortunoffs' combined stake stood at 7.6% as of a March 2026 Schedule 13D (Gregory at 5.9%, Scott at 1.7%), and the same filing's transaction exhibit shows both continuing to buy stock and trade call options through January 2026 [SEC] Schedule 13D, March 2026 That reads as a vote of confidence, but a shareholder group giving up its board-level visibility is also one less set of eyes on governance going forward — this desk is treating it as a data point, not a settled signal.
• TAM-optimism risk: the 5-Year Growth Plan's path to $500M in direct written premium leans on geographic expansion into states — California E&S lines starting Q2 2026, and others under the broader plan — where Kingstone has no established underwriting track record, a different risk profile than the New York catastrophe specialization the current numbers are built on. It would be easy to read the growth target as confirmation of the turnaround thesis when it's actually a separate, unproven bet.
• Dilution: the equity turnaround is partly a share-count story, not purely an earnings one — weighted-average diluted shares grew 13.8% in FY2025 alone, and a 969,225-share warrant tranche tied to the 2022/2024 debt-exchange agreements was exercised in December 2025. A thesis built on per-share metrics (EPS, book value per share) needs to track whether further warrant or option exercises keep diluting the earnings growth this thesis depends on.

Valuation

At $20.21 a share against FY2025 diluted EPS of $2.88, the implied multiple is roughly 7.0x trailing earnings

That is a distressed-insurer multiple, not a turnaround-with-a-growth-plan multiple — but the honest question is whether $40.8M of FY2025 net income is a repeatable run rate or partly a function of a catastrophe year that simply didn't produce large losses. The filings don't break out how much of the expense-ratio improvement versus benign weather drove the result, so there's a real range here: if FY2025 is representative, 7.0x looks cheap for a company guiding toward roughly doubling premium by 2029; if FY2025 also reflects an unusually quiet catastrophe year, normalized earnings power is lower and the effective multiple on that basis is higher than the headline number suggests.

Re-rating Catalyst

Two things would close part of this gap. First, an FY2026 print that holds net income near or above the FY2025 level through a full underwriting year — including whatever catastrophe activity actually occurs — would support reading the 2024-2025 recovery as structural rather than a favorable-weather year layered on top of real operating improvement. Second, visible progress on the 5-Year Growth Plan — the California E&S entry actually producing premium, or additional state expansion — would give the market a growth story to price instead of just a turnaround-from-losses story, which is a different and typically better-covered category of insurer.